{
    "code": "72000018",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=72000018",
    "time": "2019-05-17 03:06:59",
    "許可證字號": "衛部罕菌疫輸字第000018號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "116\/01\/25",
    "發證日期": "106\/01\/25",
    "許可證種類": "菌　疫",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA07200001800",
    "中文品名": "&quot;安進&quot;瑞百安注射液",
    "英文品名": "&quot;Amgen&quot; Repatha Solution for Injection",
    "適應症": "同合子家族性高膽固醇血症：\r\nRepatha適用於飲食及其他降血脂療法(如：statins、ezetimibe、LDL血漿析離術)之輔助療法，用以進一步降低LDL-C，但LDLR-negative mutation之病人除外。",
    "劑型": "279注射液",
    "包裝": "1 mL(Pre-filled syringe)預填針筒 1 mL(Pre-filled SureClick Autoinjector)預填SureClick自動注射器",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "Evolocumab"
    ],
    "限制項目": "02輸　入 5F免除銜接性試驗",
    "申請商名稱": "620117N253  台灣安進藥品有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "FPR0034000  AMGEN MANUFACTURING,LIMITED",
        "製造廠廠址": "STATE ROAD 31,KM 24.6 JUNCOS,PUERTO RICO 00777-4060",
        "製造廠公司地址": ""
    },
    "CCC號列": "",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "FUS0866000  IMMUNEX RHODE ISLAND CORPORATION",
            "製造廠廠址": "40 TECHNOLOGY WAY, WEST GREENWICH RHODE ISLAND 02817, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "原料藥製造廠"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2406004500",
            "成分名稱": "Evolocumab",
            "含量描述": "",
            "含量": "140.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "衛部罕菌疫輸字第000018號_安進瑞百安注射液_中文仿單-108-04-24.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=003&Type=9"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 6-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=011&Type=8"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 5-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=010&Type=8"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 4-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=009&Type=8"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 3-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=008&Type=8"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 2-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=007&Type=8"
        },
        {
            "title": "Amgen Repatha_20180307_Carton 1-107-03-08(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=006&Type=8"
        },
        {
            "title": "Amgen Repatha_預充填針筒_標籤-106-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=005&Type=8"
        },
        {
            "title": "Amgen Repatha_預充填針筒_外盒-106-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=004&Type=8"
        },
        {
            "title": "Amgen Repatha_預充填針筒_Topweb-106-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=003&Type=8"
        },
        {
            "title": "Amgen Repatha_預充填注射筆_標籤-106-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=002&Type=8"
        },
        {
            "title": "Amgen Repatha_預充填注射筆_外盒-106-04-18.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=72000018&Seq=001&Type=8"
        }
    ]
}